<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amaresh Parimi</style></author><author><style face="normal" font="default" size="100%">Silambarasan K</style></author><author><style face="normal" font="default" size="100%">Prashantkumar Goudappala</style></author><author><style face="normal" font="default" size="100%">Ravi Mundugaru</style></author><author><style face="normal" font="default" size="100%">Parameswari Royapuram Parthasarathy</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Synergistic antioxidant and antidiabetic activities of Tinospora cordifolia and Azadirachta indica extracts supported by in-silico molecular docking and ADMET evaluation</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antioxidants</style></keyword><keyword><style  face="normal" font="default" size="100%">Azadirachta indica</style></keyword><keyword><style  face="normal" font="default" size="100%">Health</style></keyword><keyword><style  face="normal" font="default" size="100%">Plants</style></keyword><keyword><style  face="normal" font="default" size="100%">PTP1B</style></keyword><keyword><style  face="normal" font="default" size="100%">Tinospora cordifolia</style></keyword><keyword><style  face="normal" font="default" size="100%">α-amylase</style></keyword><keyword><style  face="normal" font="default" size="100%">α-glucosidase</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">310-321</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Type 2 Diabetes mellitus is a chronic metabolic disorder which worsens by increased oxidative stress resulting in other diabetes associated complications. Tinospora cordifolia (TC) and &lt;em&gt;Azadirachta indica&lt;/em&gt; (AI) are traditional medicinal plants that has been used for diabetes since ancient times, but their combined potential as a formulation has not been evaluated for the management of diabetes. &lt;strong&gt;Objectives:&lt;/strong&gt; This study aimed to profile the phytochemical composition of 70% hydroethanolic extracts of TC and AI, assess their antioxidant and antidiabetic activity individually and in combination, and further substantiate their efficacy through in-silico molecular docking and ADMET evaluation of their key bioactive compounds, berberine and nimbolide. &lt;strong&gt;Methods: &lt;/strong&gt;Hydroethanolic extracts of TC and AI were subjected to preliminary phytochemical screening, quantification of primary and secondary metabolites, and HPTLC profiling. Five combinations of TC:AI (1:1, 1:2, 2:1, 1:3, 3:1) were prepared and evaluated for antioxidant activity using DPPH, ABTS, and FRAP assays, and for antidiabetic potential using α-amylase, α-glucosidase, and PTP1B inhibition assays. IC&lt;sub&gt;₅₀&lt;/sub&gt; values were calculated. &lt;em&gt;In-silico&lt;/em&gt; studies were performed for berberine and nimbolide using AutoDock 4.2.6 against PPARγ, GLUT4, and IRS1. Drug-likeness and ADMET properties were predicted using SwissADME and pkCSM. &lt;strong&gt;Results:&lt;/strong&gt; Phytochemical profiling confirmed the presence of alkaloids, polyphenols, flavonoids, and tannins. TC demonstrated stronger inherent antioxidant and antidiabetic activity than AI. Among combinations, 1:1 and 3:1 formulations showed the highest potency with IC₅₀ values comparable to standards. Molecular docking revealed strong binding affinities of berberine and nimbolide toward PPARγ, GLUT4, and IRS1, while ADMET prediction indicated acceptable pharmacokinetic behaviour and good drug-likeness. &lt;strong&gt;Conclusion:&lt;/strong&gt; The TC:AI 1:1 formulation exhibited synergistic antioxidant and antidiabetic effects, supported by favorable &lt;em&gt;in-silico&lt;/em&gt; interactions and pharmacokinetic profiles, highlighting its potential as a natural therapeutic option for T2DM management.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">310</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Amaresh Parimi&lt;sup&gt;1,2&lt;/sup&gt;, Silambarasan K&lt;sup&gt;3&lt;/sup&gt;, Prashantkumar Goudappala&lt;sup&gt;4&lt;/sup&gt;, Ravi Mundugaru&lt;sup&gt;5&lt;/sup&gt;, Parameswari Royapuram Parthasarathy&lt;sup&gt;3*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai–602105, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology, Navodaya Medical College hospital and Research Centre, Raichur Karnataka, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Molecular Biochemistry Lab, Department of Biochemistry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai–602105, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Biochemistry, Sri Siddhartha Medical College, Sri Siddhartha Academy of Higher Education, Tumkur–572107, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Pharmacology, Adichunchangari Institute of Medical Sciences, B.G Nagar Mandya Karnataka, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sesilia Rante Pakadang</style></author><author><style face="normal" font="default" size="100%">Maria Hilaria</style></author><author><style face="normal" font="default" size="100%">Sisilia Teresia Rosmala Dewi</style></author><author><style face="normal" font="default" size="100%">Santi Sinala</style></author><author><style face="normal" font="default" size="100%">Jumain</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">MIC and MKC Analysis of Herbal Medicine in Indonesia Against Mycobacterium tuberculosis</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antituberculosis</style></keyword><keyword><style  face="normal" font="default" size="100%">MIC</style></keyword><keyword><style  face="normal" font="default" size="100%">MKC</style></keyword><keyword><style  face="normal" font="default" size="100%">Plants</style></keyword><keyword><style  face="normal" font="default" size="100%">Potential</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1058-1064</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Data shows that the success of the Directly Observed Treatment Shortcourse program(DOTS) in South Sulawesi Province was 74.8%. Causes of failure include standard drug side effects, length of treatment period and &lt;em&gt;Mycobacterium tuberculosis &lt;/em&gt;(M.tb) bacterial resistance. The development of new drugs today in addition to synthetic chemical drugs are also natural materials that have the potential as antituberculosis with various mechanisms. The aim of the research is to prove the potential of plants used by the community as tuberculosis drugs empirically based on phytochemical screening extracts, M.tb sensitivity to extracts and determine the MIC (Minimum Inhibitory Concentration) and MKC (Minimum Killing Concentration) values of M.tb. Selection of plant test materials based on survey results and Riskesdas data in 2015. Testing the potential of plant extracts based on the sensitivity of M.tb to the test material &lt;em&gt;in vitro&lt;/em&gt; with an incubation period of 7 weeks. Showed 25 plants that have been used empirically as tuberculosis drugs proved to be potential antibacterial M.tb. Phytochemical screening produces flavonoids and tannins in all extracts. Some extracts contain alkaloids, saponins and steroids. Potential tests show that the extract concentration that is effectively used as a tuberculosis drug is: Meniran leaves and miana 100 ppm. Banana peel and basil leaves 125 ppm. 150 ppm bangle rhizome. Turmeric rhizome 175 ppm. Roselle flowers, soursop leaves and lime 200 ppm. Sandalwood, bitter melon leaves and binahong 225 ppm, Curcuma rhizome, kencur, turmeric and onion tubers, gotu kola leaves, sea lava and papaya 275 ppm. Ginger rhizome, brotowali stem, noni leaf, cloves and mangosteen peel &amp;gt; 275 ppm. 90% garlic bulb extract.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1058</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Sesilia Rante Pakadang&lt;sup&gt;1&lt;/sup&gt;, Maria Hilaria&lt;sup&gt;2&lt;/sup&gt;, Sisilia Teresia Rosmala Dewi&lt;sup&gt;1&lt;/sup&gt;, Santi Sinala&lt;sup&gt;1,&lt;/sup&gt;*, Jumain&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Health Polytechnic of the Makassar Ministry of Health, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Health Polytechnic of the Kupang Ministry of Health, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abdullahi Temitope Jamiu</style></author><author><style face="normal" font="default" size="100%">Christiana Eleojo Aruwa</style></author><author><style face="normal" font="default" size="100%">Ismail Abiodun Abdulakeem</style></author><author><style face="normal" font="default" size="100%">Abdulwakeel Ayokunnun Ajao</style></author><author><style face="normal" font="default" size="100%">Saheed SABIU</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Phytotherapeutic Evidence Against Coronaviruses and Prospects for COVID-19</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antivirals</style></keyword><keyword><style  face="normal" font="default" size="100%">Coronavirus</style></keyword><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">Drug target</style></keyword><keyword><style  face="normal" font="default" size="100%">Natural products</style></keyword><keyword><style  face="normal" font="default" size="100%">Plant metabolites</style></keyword><keyword><style  face="normal" font="default" size="100%">Plants</style></keyword><keyword><style  face="normal" font="default" size="100%">SARS-CoV-2</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1252-1267</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The emergence of the novel β-coronavirus (SARS-CoV-2) and subsequent outbreak of COVID-19, is a global health challenge with no known treatment to date and has culminated in significant morbidity and mortality. This article highlights current understanding on SARSCoV- 2 based on the available scientific evidence on human coronavirus (HCoV) infections, which could offer novel insights and therapeutic targets for SARS-CoV-2, the causative agent of COVID-19. Specifically, the paper presents available phytotherapeutic evidence against pathogenic HCoVs with a view to identifying potent plant-derived antiviral agents that could be developed to aid the fight against coronaviruses and the current COVID-19. Evidently, elucidation of CoV integral proteins such as the spike protein, angiotensin-converting enzyme 2, 3C-like cysteine protease and papain-like protease, as good targets for drug developments has lent credence to the use of medicinal plants or their metabolites as prophylaxis or treatment interventions in CoV infections and holds promising ground for SARS-CoV-2. While some promising phytocompounds are currently under clinical trials for COVID-19, increased research into plants and in-depth characterization of their metabolites could reveal more interesting results that would benefit humanity in its fight against emerging and re-emerging viral infections including the current COVID-19. Overall, given the current body of evidence on the potential development of phytotherapeutics for COVID-19, fears need to be allayed while clinical trials continue. Conclusively, the lockdown and other preventive measures which have been implemented in most parts of the world should be humanely exercised and supported to ensure compliance and safety of lives.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1252</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Abdullahi Temitope Jamiu&lt;sup&gt;2&lt;/sup&gt;, Christiana Eleojo Aruwa&lt;sup&gt;1&lt;/sup&gt;, Ismail Abiodun Abdulakeem&lt;sup&gt;3,&lt;/sup&gt; Abdulwakeel Ayokun-nun Ajao&lt;sup&gt;4&lt;/sup&gt; and Saheed Sabiu&lt;sup&gt;1,&lt;/sup&gt;*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biotechnology and Food Technology, Durban University of Technology, P.O. Box 1334, Durban, 4000, SOUTH AFRICA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Microbial, Biochemical and Food Technology, University of the Free State, Bloemfontein 9300, SOUTH AFRICA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Biological Sciences, Al- Hikmah University, Ilorin, NIGERIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Botany and Plant Biotechnology, University of Johannesburg, P.O. Box 524, Auckland Park APK, 2006, SOUTH AFRICA.&lt;/p&gt;
</style></auth-address></record></records></xml>